Interferon-α-related thyroid disease:: Pathophysiological, epidemiological, and clinical aspects

被引：99

作者：

Carella, C

Mazziotti, G

Amato, G

Braverman, LE

Roti, E

机构：

[1] Boston Univ, Med Ctr, Sect Endocrinol Diabet & Nutr, Sch Med, Boston, MA 02118 USA

[2] Univ Naples 2, Dept Clin & Expt Med F Magrassi & A Lanzara, I-80121 Naples, Italy

[3] Univ Milan, Inst Endocrinol, I-20133 Milan, Italy

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2004年 / 89卷 / 08期

关键词：

D O I：

10.1210/jc.2004-0627

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3656 / 3661

页数：6

共 96 条

[1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].

Alter, MJ ;

Kruszon-Moran, D ;

Nainan, OV ;

McQuillan, GM ;

Gao, FX ;

Moyer, LA ;

Kaslow, RA ;

Margolis, HS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562

[2] THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].

BARON, S ;

TYRING, SK ;

FLEISCHMANN, WR ;

COPPENHAVER, DH ;

NIESEL, DW ;

KLIMPEL, GR ;

STANTON, GJ ;

HUGHES, TK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383

[3] REVERSIBILITY OF THYROID-DYSFUNCTION INDUCED BY RECOMBINANT ALPHA-INTERFERON IN CHRONIC HEPATITIS-C [J].

BAUDIN, E ;

MARCELLIN, P ;

POUTEAU, M ;

COLASLINHART, N ;

LEFLOCH, JP ;

LEMMONIER, C ;

BENHAMOU, JP ;

BOK, B .

CLINICAL ENDOCRINOLOGY, 1993, 39 (06) :657-661

[4] The spectrum of liver disease in the general population: lesson from the Dionysos study [J].

Bellentani, S ;

Tiribelli, C .

JOURNAL OF HEPATOLOGY, 2001, 35 (04) :531-537

[5] Treatment with ribavirin and interferon-α reduces interferon-γ expression in patients with chronic hepatitis C [J].

Bergamini, A ;

Bolacchi, F ;

Cepparulo, M ;

Demin, F ;

Uccella, I ;

Bongiovanni, B ;

Ombres, D ;

Angelico, F ;

Liuti, A ;

Hurtova, M ;

Francioso, S ;

Carvelli, C ;

Cerasari, G ;

Angelico, M ;

Rocchi, G .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03) :459-464

[6] Lack of evidence for the Th2 predominance in patients with chronic hepatitis C [J].

Bergamini, A ;

Bolacchi, F ;

Cerasari, G ;

Carvelli, C ;

Faggioli, E ;

Cepparulo, M ;

Demin, F ;

Uccella, I ;

Bongiovanni, B ;

Niutta, P ;

Capozzi, M ;

Lupi, M ;

Piscitelli, E ;

Rocchi, G ;

Angelico, M .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03) :451-458

[7] THYROID-DYSFUNCTION AND LIVER-INJURY FOLLOWING ALPHA-INTERFERON TREATMENT OF CHRONIC VIRAL-HEPATITIS [J].

BERRIS, B ;

FEINMAN, SV .

DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (11) :1657-1660

[8]

Binaghi M, 2002, J FR OPHTALMOL, V25, P412

[9] Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: A prospective, randomized study [J].

Bogazzi, F ;

Bartalena, L ;

Cosci, C ;

Brogioni, S ;

Dell'Unto, E ;

Grasso, L ;

Aghini-Lombardi, F ;

Rossi, G ;

Pinchera, A ;

Braverman, LE ;

Martino, E .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) :1999-2002

[10] Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis [J].

Bogazzi, F ;

Bartalena, L ;

Brogioni, S ;

Mazzeo, S ;

Vitti, P ;

Burelli, A ;

Bartolozzi, C ;

Martino, E .

THYROID, 1997, 7 (04) :541-545

← 1 2 3 4 5 6 7 8 9 10 →